Prevalence and clinical characteristics of hospitalized children with community-acquired Mycoplasma pneumoniae pneumonia during 2017/2018, Chengde, China
- PMID: 33592835
- PMCID: PMC7870167
- DOI: 10.1097/MD.0000000000023786
Prevalence and clinical characteristics of hospitalized children with community-acquired Mycoplasma pneumoniae pneumonia during 2017/2018, Chengde, China
Abstract
Community acquired-pneumonia (CAP) has varying causative pathogens and clinical characteristics. This study investigated the prevalence of Mycoplasma pneumoniae (M pneumoniae) and evaluated the clinical characteristics in infected hospitalized children by disease severity.From throat swabs of hospitalized children (5 months to 14 years) with CAP collected between November 2017 and May 2018, M pneumoniae and other CAP pathogens were identified using polymerase chain reaction (PCR). Differences in clinical and laboratory test data were compared between severe and mild case groups.Of 333 hospitalized children enrolled, 221/333 (66.4%) tested positive for M pneumoniae and 24/221 (10.9%) patients were (n = 9, aged <5 years vs n = 15, ≥5 years) single infection by PCR, however, only 170/333 (51.1%) patients were presented with M pneumoniae IgM-positive. M pneumoniae detection rate by PCR was higher than by immunoglobulin (IgM) serology. In 123/221 (55.7%) M pneumoniae infected patients, coinfection with bacterial pathogens (n = 61, <5 years vs n = 62, ≥5 years) occurred. Children (aged 3-8 years) had most M pneumoniae infection. Severe M pneumoniae pneumonia (MPP) in children occurred mostly in older age (7 [interquartile ranges {IQR}, 6-8] years; P < .0001), with longer cough days (14 [IQR, 10-19.5] days; P = .002) and hospitalization duration (9.5 [IQR, 7-12.3] days; P < .0001), lower lymphocyte ratio (24.1, [IQR, 20.0-31.1] %; P = .001), higher neutrophils ratio (66.0, [IQR, 60.2-70.3]%; P < .0001), and serum C-reactive protein (CRP) level (3.8, [IQR, 1.3-10.9] mg/L; P = .027).M pneumoniae is the most commonly detected pathogen in CAP. High coinfection prevalence increases diagnosis difficulty by clinically nonspecific characteristics. M pneumoniae detection by PCR with IgM may improve precise and reliable diagnosis of community-acquired MPP.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures

Similar articles
-
Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance.J Microbiol Immunol Infect. 2015 Dec;48(6):632-8. doi: 10.1016/j.jmii.2014.08.003. Epub 2014 Oct 11. J Microbiol Immunol Infect. 2015. PMID: 25311405
-
Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.Ital J Pediatr. 2014 Dec 18;40:104. doi: 10.1186/s13052-014-0104-4. Ital J Pediatr. 2014. PMID: 25518734 Free PMC article.
-
Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired Pneumonia.JAMA Dermatol. 2020 Feb 1;156(2):144-150. doi: 10.1001/jamadermatol.2019.3602. JAMA Dermatol. 2020. PMID: 31851288 Free PMC article.
-
Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.Indian J Med Res. 2018 Jan;147(1):23-31. doi: 10.4103/ijmr.IJMR_1582_16. Indian J Med Res. 2018. PMID: 29749357 Free PMC article. Review.
-
Biomarkers associated with the diagnosis and prognosis of Mycoplasma pneumoniae pneumonia in children: a review.Front Cell Infect Microbiol. 2025 Mar 18;15:1552144. doi: 10.3389/fcimb.2025.1552144. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40171163 Free PMC article. Review.
Cited by
-
Clinical differences between Mycoplasma pneumoniae pneumonia and Streptococcus pneumoniae pneumonia: a case control study.Front Pediatr. 2024 Jul 19;12:1409687. doi: 10.3389/fped.2024.1409687. eCollection 2024. Front Pediatr. 2024. PMID: 39100649 Free PMC article.
-
Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model.Eur J Pediatr. 2023 Mar;182(3):1239-1249. doi: 10.1007/s00431-022-04761-9. Epub 2023 Jan 12. Eur J Pediatr. 2023. PMID: 36633659 Free PMC article.
-
Identification of Mycoplasma pneumoniae-associated pneumonia cases among hospitalized patients using CLART® microarray technology.J Int Med Res. 2022 Sep;50(9):3000605221123678. doi: 10.1177/03000605221123678. J Int Med Res. 2022. PMID: 36171729 Free PMC article.
-
Mycoplasma pneumoniae Seroprevalence and Total IgE Levels in Patients with Juvenile Idiopathic Arthritis.J Immunol Res. 2021 Oct 6;2021:6596596. doi: 10.1155/2021/6596596. eCollection 2021. J Immunol Res. 2021. PMID: 34660816 Free PMC article.
-
Comparison of serodiagnosis methods for community-acquired Mycoplasma pneumoniae respiratory tract infections in children.Medicine (Baltimore). 2023 Jul 21;102(29):e34133. doi: 10.1097/MD.0000000000034133. Medicine (Baltimore). 2023. PMID: 37478238 Free PMC article.
References
-
- Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015;385:430–40. - PubMed
-
- Arnold FW, Summersgill JT, Lajoie AS, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med 2007;175:1086–93. - PubMed
-
- Bartlett JG. Is activity against “atypical” pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin Infect Dis 2008;47: suppl: S232–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous